The effect of switching to aripiprazole on indices of cardiovascular health in overweight and obese patients with schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 14 Jan 2008
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Jan 2008 Status changed from in progress to completed.
- 29 Oct 2005 New trial record.